Ignota Labs has been featured in Technology Networks feature about the challenges faced by Biotech Start-Ups.
Scientific research helps us to make sense of the world around us, and even change it. A fascination with the pursuit of discovery, and the possibility of having an impact on society, is often the underlying motivation for pursuing a career in science. But to deliver that impact, you might need to take your discovery beyond the walls of the laboratory and enter the realms of scientific entrepreneurship.
The resilience of life science entrepreneurship shines through the UK Bioindustry Association’s biotech financing 2023 report. UK biotech companies secured £1.8 billion in equity financings in 2022, in spite of the global economic downturn. The UK also maintained its position as Europe’s leading biotech hub, contributing to 41% of the total venture capital raised across the continent. The industry appears to be thriving, but that’s not to say the journey from research scientist to successful start-up has a linear trajectory – there are a myriad of barriers to overcome.
At the European Laboratory Research and Innovation Group’s (ELRIG) Research and Innovation 2024 event, we asked a selection of start-up companies in the biotech space the same question: what are the key challenges you currently face?
Read more:
‘Technology Networks Drug Discovery - Breaking Barriers: The Challenges Faced by 6 Biotech Start-Ups in 2024’ can be read in full at Technology Networks Drug Discovery.
Authored by: Molly Coddington
Published: 27 March 2024 by Technology Networks
